BioNap, Inc.

Earlier this week, I had a chance to speak with Henry Sicignano III, President & CEO of 22nd Century Group, Inc. (NYSEMKT: XXII).

Why BioSig Technologies, Inc. may be a medical device name worth adding to your portfolio.

NASDAQ-listed shares have appreciated 50% in the past month.

Earlier this week, BriaCell Therapeutics Corp (BCT.V) (BCTXF) announced it is planning to initiate a Phase 1/2 study with BriaVax™ in the second quarter 2016.

Last week, Can-Fite Biopharma Ltd (CANF) filed its annual report and provided a clinical and business update for investors.

BioSig Technologies, Inc. (BSGM) is a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace.

Earlier in March 2016, Celator Pharmaceuticals (CPXX) announced positive top-line results from the company's Phase 3 clinical trial testing VYXEOS™ (cytarabine + daunorubicin liposome injection) in patients with high-risk (secondary) acute myeloid...